Search Publications

Publications

Pubmed ID Author Year Title

17980017

Koulouri O

2008

A systematic review of commonly used medical treatments for hirsutism in women.

17980363

Palomba S

2008

Pretreatment with oral contraceptives in infertile anovulatory patients with polycystic ovary syndrome who receive gonadotropins for controlled ovarian stimulation.

17980364

Panidis D

2008

Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.

17982352

Bl?her S

2007

Leptin in reproduction.

17982356

Pasquali R

2007

Obesity and infertility.

17983490

Chen SL

2007

[Clinical outcome of patients with follicular development retardation by prolonged duration of gonadotropin administration for in vitro fertilization].

17983511

Chen YX

2007

[Diagnostic value of ovarian morphology by ultrasonography in pubertal polycystic ovary syndrome].

17983512

Zhao JL

2007

[Investigation of body hair assessment of Chinese women in Shandong region and its preliminary application in polycystic ovary syndrome patients].

17984248

Tan S

2007

Metformin improves polycystic ovary syndrome symptoms irrespective of pre-treatment insulin resistance.

17984855

El-Gabalawi F

2007

Hypersexuality in inpatient children and adolescents: recognition, differential diagnosis, and evaluation.

17986278

Lee JW

2008

Retinol-binding protein in nonobese women with polycystic ovary syndrome.

17986642

Heutling D

2008

Asymmetrical dimethylarginine, inflammatory and metabolic parameters in women with polycystic ovary syndrome before and after metformin treatment.

17987887

Sikka P

2007

Ultrasonography of the ovaries and its correlation with clinical and endocrine parameters in infertile women with PCOS.

17990452

Wu JH

2007

[Clinical study on effect of Bushen Huayu Qutan Recipe in treating polycystic ovarian syndrome].

17991119

Mohiuddin S

2007

Long-term follow up of women with laparoscopic ovarian diathermy for women with clomiphene-resistant polycystic ovarian syndrome.

18000084

Escobar-Morreale HF

2008

A prospective study of the prevalence of nonclassical congenital adrenal hyperplasia among women presenting with hyperandrogenic symptoms and signs.

18000088

Legro RS

2008

Ovulatory response to treatment of polycystic ovary syndrome is associated with a polymorphism in the STK11 gene.

18000176

Glintborg D

2008

Soluble CD36 and risk markers of insulin resistance and atherosclerosis are elevated in polycystic ovary syndrome and significantly reduced during pioglitazone treatment.

18000969

Barness LA

2007

Obesity: genetic, molecular, and environmental aspects.

18001723

Zolghadri J

2008

Relationship between abnormal glucose tolerance test and history of previous recurrent miscarriages, and beneficial effect of metformin in these patients: a prospective clinical study.

18003945

Walters KA

2008

Androgen actions and the ovary.

18006561

Fauser BC

2008

Predictors of ovarian response: progress towards individualized treatment in ovulation induction and ovarian stimulation.

18007129

Hart R

2007

Polycystic ovarian syndrome--prognosis and treatment outcomes.

18019873

Julson H

2007

Effectiveness of insulin sensitizing drugs for polycystic ovary syndrome.

18022165

Wei Z

2008

Effect of metformin pretreatment on pregnancy outcome of in vitro matured oocytes retrieved from women with polycystic ovary syndrome.

18024952

Cascella T

2008

Visceral fat is associated with cardiovascular risk in women with polycystic ovary syndrome.

18028738

El-Halawaty S

2007

Clinical significance of serum concentration of anti-M?llerian hormone in obese women with polycystic ovary syndrome.

18029284

Lin S

2008

Plasminogen activator and plasma activator inhibitor-1 in young women with polycystic ovary syndrome.

18034780

Amato MC

2008

The evaluation of metabolic parameters and insulin sensitivity for a more robust diagnosis of the polycystic ovary syndrome.

18041407

Radakovi? B

2007

MTHFR C 677T mutation and 4G/5G PAI-1 polymorphism in patient with polycystic ovarian syndrome.

18043788

Esler DM

2007

The psychosocial experience of women with PCOS--a case control study.

18043834

Tien JC

2007

Non-surgical interventions for threatened and recurrent miscarriages.

18045126

Reynolds MF

2007

Valproate and neuroendocrine changes in relation to women treated for epilepsy and bipolar disorder: a review.

18047551

Stener-Victorin E

2008

Acupuncture in polycystic ovary syndrome: current experimental and clinical evidence.

18050612

Wertheim K

2007

[Search for the etiopathogenesis of polycystic ovary syndrome (PCOS)].

18053115

Morton A

2008

Don't forget OSA with PCOS!

18054923

Cosar E

2008

Polycystic ovary syndrome is related to idiopathic intracranial hypertension according to magnetic resonance imaging and magnetic resonance venography.

18055040

Tekin G

2008

Altered autonomic neural control of the cardiovascular system in patients with polycystic ovary syndrome.

18055135

Sarkar C

2008

Deciphering the cis-regulatory elements of co-expressed genes in PCOS by in silico analysis.

18056718

Kajitani T

2008

Analysis of serum FSH bioactivity in a patient with an FSH-secreting pituitary microadenoma and multicystic ovaries: A case report.

18056772

Valkenburg O

2008

A more atherogenic serum lipoprotein profile is present in women with polycystic ovary syndrome: a case-control study.

18056778

Salley KE

2007

Glucose intolerance in polycystic ovary syndrome--a position statement of the Androgen Excess Society.

18061817

Futterweit W

2007

Polycystic ovary syndrome: a common reproductive and metabolic disorder necessitating early recognition and treatment.

18063948

Shi Y

2007

Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.

18064932

van Zuuren EJ

2007

[Hirsutism].

18065576

Moran LJ

2007

Postprandial ghrelin, cholecystokinin, peptide YY, and appetite before and after weight loss in overweight women with and without polycystic ovary syndrome.

18071341

Florakis D

2008

Effect of hypocaloric diet plus sibutramine treatment on hormonal and metabolic features in overweight and obese women with polycystic ovary syndrome: a randomized, 24-week study.

18073308

Das M

2008

Granulosa cell survival and proliferation are altered in polycystic ovary syndrome.

18073681

Elghblawi E

2007

Polycystic ovary syndrome and female reproduction.

18074422

Jensterle M

2007

Decreased androgen levels and improved menstrual pattern after angiotensin II receptor antagonist telmisartan treatment in four hypertensive patients with polycystic ovary syndrome: case series.

18074942

Gerli S

2007

Randomized, double blind placebo-controlled trial: effects of myo-inositol on ovarian function and metabolic factors in women with PCOS.

18075283

Micic D

2007

Total ghrelin levels during acute insulin infusion in patients with polycystic ovary syndrome.

18075845

Lunde O

2007

Polycystic ovary syndrome: a follow-up study on diabetes mellitus, cardiovascular disease and malignancy 15-25 years after ovarian wedge resection.

18075846

Oktenli C

2007

Metformin decreases circulating acylation-stimulating protein levels in polycystic ovary syndrome.

18078863

Sam S

2008

Evidence for pancreatic beta-cell dysfunction in brothers of women with polycystic ovary syndrome.

18081147

McGill DJ

2007

A randomised, split-face comparison of facial hair removal with the alexandrite laser and intense pulsed light system.

18081596

Shaw LM

2008

Polycystic ovary syndrome: a transgenerational evolutionary adaptation.

18081798

Mofid A

2008

Hirsutism.

18081939

Dumesic DA

2008

Polycystic ovary syndrome and oocyte developmental competence.

18082737

McGovern PG

2008

Medication adherence and treatment success in the National Institute of Child Health and Human Development-Reproductive Medicine Network's Pregnancy in Polycystic Ovary Syndrome Trial.

18082748

Cosar E

2008

Resting metabolic rate and exercise capacity in women with polycystic ovary syndrome.

18082857

Nader S

2007

Adrenarche and polycystic ovary syndrome: a tale of two hypotheses.

18083746

Franks S

2008

Cyproterone acetate/ethinyl estradiol for acne and hirsutism: time to revise prescribing policy.

18087838

Gutman G

2007

[Long-term health consequences of polycystic ovaries syndrome: metabolic, cardiovascular and oncological aspects].

18089693

Barber TM

2008

Global adiposity rather than abnormal regional fat distribution characterizes women with polycystic ovary syndrome.

18090834

Brown MA

2007

Polycystic ovary syndrome: clinical and imaging features.

18091663

Cho LW

2007

Cardiovascular risk in women with polycystic ovary syndrome.

18092000

Huang AM

2007

The Cebpd (C/EBPdelta) gene is induced by luteinizing hormones in ovarian theca and interstitial cells but is not essential for mouse ovary function.

18092729

Touraine P

2007

[Amenorrhoea].

18094354

Veiga-Lopez A

2008

Developmental programming: deficits in reproductive hormone dynamics and ovulatory outcomes in prenatal, testosterone-treated sheep.

18097891

Farshchi H

2007

Diet and nutrition in polycystic ovary syndrome (PCOS): pointers for nutritional management.

18133560

STEIN IF

1949

Results of bilateral ovarian wedge resection in 47 cases of sterility; 20 year end results; 75 cases of bilateral polycystic ovaries.

18156101

Regitz-Zagrosek V

2007

Gender aspects of the role of the metabolic syndrome as a risk factor for cardiovascular disease.

18156650

Cort?n M

2008

Proteomic analysis of human omental adipose tissue in the polycystic ovary syndrome using two-dimensional difference gel electrophoresis and mass spectrometry.

18157386

Barcellos CR

2007

Impact of body mass index on blood pressure levels in patients with polycystic ovary syndrome.

18158291

Palomba S

2008

Structured exercise training programme versus hypocaloric hyperproteic diet in obese polycystic ovary syndrome patients with anovulatory infertility: a 24-week pilot study.

18163993

Moran C

2008

Obesity differentially affects serum levels of androstenedione and testosterone in polycystic ovary syndrome.

18165118

Herzog AG

2008

Disorders of reproduction in patients with epilepsy: primary neurological mechanisms.

18166179

Badawy A

2009

Clomiphene citrate or anastrozole for ovulation induction in women with polycystic ovary syndrome? A prospective controlled trial.

18166189

Romualdi D

2008

Is there a role for soy isoflavones in the therapeutic approach to polycystic ovary syndrome? Results from a pilot study.

18166296

Wild RA

2008

Pioglitazone and metformin for increased small low-density lipoprotein in polycystic ovary syndrome: counterpoint.

18166299

Rizzo M

2008

How should we manage atherogenic dyslipidemia in women with polycystic ovary syndrome?

18166827

Lavou? V

2008

Restoration of ovulation after unilateral ovariectomy in a woman with McCune-Albright syndrome: a case report.

18172174

Nestler JE

2008

Metformin for the treatment of the polycystic ovary syndrome.

18173145

Li XP

2007

[Correlation between sex hormone and insulin and various TCM syndrome types in patients with polycystic ovarian syndrome].

18174521

Tan BK

2008

Omentin-1, a novel adipokine, is decreased in overweight insulin-resistant women with polycystic ovary syndrome: ex vivo and in vivo regulation of omentin-1 by insulin and glucose.

18175285

Mina A

2007

Hemostatic dysfunction associated with endocrine disorders as a major risk factor and cause of human morbidity and mortality: a comprehensive meta-review.

18177867

Begum MR

2009

Comparison of efficacy of aromatase inhibitor and clomiphene citrate in induction of ovulation in polycystic ovarian syndrome.

18178198

Chang W

2008

Adipocytes from women with polycystic ovary syndrome demonstrate altered phosphorylation and activity of glycogen synthase kinase 3.

18178226

Moran LJ

2008

Genome instability is increased in lymphocytes of women with polycystic ovary syndrome and is correlated with insulin resistance.

18178908

Sattar N

2008

Polycystic ovarian syndrome, biomarkers, and metformin: research, risk, and reality.

18181076

Legro RS

2008

New directions in polycystic ovary syndrome.

18181077

Goodarzi MO

2008

Looking for polycystic ovary syndrome genes: rational and best strategy.

18181078

Yu Ng EH

2008

Polycystic ovary syndrome in asian women.

18181079

Allahbadia GN

2008

Polycystic ovary syndrome in the Indian Subcontinent.

18181080

Coney P

2008

Does polycystic ovary syndrome increase the disparity in metabolic syndrome and cardiovascular-related health for African-American women?

18181081

Dokras A

2008

Cardiovascular disease risk factors in polycystic ovary syndrome.

18181082

Janssen OE

2008

Mood and sexual function in polycystic ovary syndrome.

18181083

Dumesic DA

2008

Implications of polycystic ovary syndrome on oocyte development.

18181084

Navaratnarajah R

2008

Polycystic ovary syndrome and endometrial cancer.